Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD30-positive Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06176690
What this trial is testing

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

Who this might be right for
CD30-Positive Diffuse Large B-Cell LymphomaAnaplastic Large Cell Lymphoma, T Cell and Null Cell TypeAnaplastic Large Cell Lymphoma, ALK-Positive+4 more
Baylor College of Medicine 90
Not applicableLooking for participantsNCT06850285
What this trial is testing

CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma

Who this might be right for
Lymphoma, B-Cell
Shanxi Bethune Hospital 15
Early research (Phase 1)Study completedNCT00430846
What this trial is testing

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

Who this might be right for
Lymphoma, Non-HodgkinDisease, HodgkinLymphoma, Large-Cell, Anaplastic
Seagen Inc. 45
Large-scale testing (Phase 3)UnknownNCT06186986
What this trial is testing

CD30 Imaging in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphoma
University Medical Center Groningen 20
Testing effectiveness (Phase 2)Study completedNCT01994850
What this trial is testing

Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients

Who this might be right for
CD30 Positive Primary Mediastinal Large B-cell LymphomaCD30-Positive Diffuse Large B-Cell LymphomaCD30-Positive Gray Zone Lymphoma
Abramson Cancer Center at Penn Medicine 32
Testing effectiveness (Phase 2)Study completedNCT02423291
What this trial is testing

SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory PMLBCL

Who this might be right for
Primary Mediastinal Large B Cell Lymphoma
Fondazione Italiana Linfomi - ETS 15
Testing effectiveness (Phase 2)Study completedNCT02388490
What this trial is testing

Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas

Who this might be right for
Relapsed or Refractory EBV-and CD30-positive Lymphomas
Seoul National University Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT05313243
What this trial is testing

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

Who this might be right for
T-Cell Lymphoma
Yale University 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT01352520
What this trial is testing

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

Who this might be right for
CD-30 Positive Anaplastic Large T-cell Cutaneous LymphomaLymphoma, Primary Cutaneous Anaplastic Large CellLymphomatoid Papulosis+5 more
M.D. Anderson Cancer Center 79
Testing effectiveness (Phase 2)Active Not RecruitingNCT05673785
What this trial is testing

Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

Who this might be right for
Lymphoma
Takeda 52
Not applicableStudy completedNCT04837222
What this trial is testing

Brentuximab Vedotin in Adults With CD30-positive Lymphoma

Who this might be right for
Lymphoma
Takeda 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02169505
What this trial is testing

Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 2
Early research (Phase 1)Study completedNCT03302728
What this trial is testing

Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralHodgkin Lymphoma
Peter MacCallum Cancer Centre, Australia 6
Large-scale testing (Phase 3)Study completedNCT01777152
What this trial is testing

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

Who this might be right for
Anaplastic Large-Cell LymphomaNon-Hodgkin LymphomaT-Cell Lymphoma
Seagen Inc. 452
Early research (Phase 1)UnknownNCT01645293
What this trial is testing

Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides

Who this might be right for
CD30 Positive Cutaneous T Cell LymphomaCD30 Positive Transformed Mycosis Fungoides
University of Cologne 15
Testing effectiveness (Phase 2)Looking for participantsNCT03356054
What this trial is testing

Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse

Who this might be right for
DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland 37
Early research (Phase 1)WithdrawnNCT02780011
What this trial is testing

Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies

Who this might be right for
CD30-positive LymphomaCD30-positive Solid Tumor
Eric Bernicker, MD
Testing effectiveness (Phase 2)UnknownNCT02274584
What this trial is testing

CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)

Who this might be right for
Lymphomas
Peking University 20
Large-scale testing (Phase 3)Study completedNCT01578499
What this trial is testing

Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

Who this might be right for
Primary Cutaneous Anaplastic Large Cell LymphomaMycosis FungoidesCutaneous T-Cell Lymphoma
Millennium Pharmaceuticals, Inc. 131
Early research (Phase 1)Looking for participantsNCT05544968
What this trial is testing

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Who this might be right for
Hodgkin DiseaseCD30-Positive Diffuse Large B-Cell LymphomaCD30+ Anaplastic Large Cell Lymphoma+4 more
Medical College of Wisconsin 42
Next Page